Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Aurinia Pharmaceuticals Inc. |
Description | Investors & Media Careers Contact Us Home About Us Overview Management Team Board of Directors Scientific Advisors Partnering Worldwide Locations Our Focu |
Keywords | N/A |
WebSite | auroralnstudy.com |
Host IP | 15.197.142.173 |
Location | United States |
Site | Rank |
US$1,124
Last updated: 2023-05-13 02:55:03
auroralnstudy.com has Semrush global rank of 0. auroralnstudy.com has an estimated worth of US$ 1,124, based on its estimated Ads revenue. auroralnstudy.com receives approximately 129 unique visitors each day. Its web server is located in United States, with IP address 15.197.142.173. According to SiteAdvisor, auroralnstudy.com is safe to visit. |
Purchase/Sale Value | US$1,124 |
Daily Ads Revenue | US$1 |
Monthly Ads Revenue | US$31 |
Yearly Ads Revenue | US$373 |
Daily Unique Visitors | 8 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
auroralnstudy.com. | A | 600 | IP: 15.197.142.173 |
auroralnstudy.com. | A | 600 | IP: 3.33.152.147 |
auroralnstudy.com. | NS | 3600 | NS Record: ns52.domaincontrol.com. |
auroralnstudy.com. | NS | 3600 | NS Record: ns51.domaincontrol.com. |
Investors & Media Careers Contact Us Home About Us Overview Management Team Board of Directors Scientific Advisors Partnering Worldwide Locations Our Focus Our Pipeline Our Medicine Product Patient Safety For Patients/Healthcare Providers Lupus Nephritis (LN) Resources Expanded Access Policy Aurinia Alliance Giving Page Investors & Media Careers Contact Us Investors & Media Careers Contact Us Changing the course of autoimmune disease Inspired by patients. Driven to make an impact. Latest News May 9, 2023 • 6:00am EDT Aurinia Pharmaceuticals Announces Kidney Biopsies Sub-study Data from the LUPKYNIS® (voclosporin) AURORA 2 Clinical Trial Presented at Congress of Clinical Rheumatology East Conference Read Press Release View All News May 4, 2023 • 6:00am EDT Aurinia Pharmaceuticals Reports First Quarter 2023 Financial and Operational Results Read Press Release View All News May 3, 2023 • 7:51am EDT Aurinia Pharmaceuticals Announces NICE Recommendation of LUPKYNIS® (Voclosporin) For |
HTTP/1.1 405 Not Allowed Server: awselb/2.0 Date: Mon, 20 Dec 2021 13:11:47 GMT Content-Length: 0 Connection: keep-alive WAFRule: HTTPMethodNOTAllowed |
Domain Name: AURORALNSTUDY.COM Registry Domain ID: 2147284192_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.wildwestdomains.com Registrar URL: http://www.wildwestdomains.com Updated Date: 2021-07-27T17:33:38Z Creation Date: 2017-07-26T23:39:22Z Registry Expiry Date: 2023-07-26T23:39:22Z Registrar: Wild West Domains, LLC Registrar IANA ID: 440 Registrar Abuse Contact Email: abuse@wildwestdomains.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS51.DOMAINCONTROL.COM Name Server: NS52.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-12-24T08:14:58Z <<< |